Разработана вакцина против covid-19


Somatotropin of prolonged action
the Eurasian application for invention No. 201892353 stated 14.11.2018

A prolonged-acting somatotropin has been developed, including somatotropin and part of the Fc-fragment of IgG1, modified by the inclusion of a five-fold series of amplifier of the hydrodynamic radius, connected by a flexible bridge.

The preparation of the developed somatotropin, the preparation for the synthesis of the developed somatotropin in the target organism allow, mainly, to obtain a prolonged effect of human growth hormone in vivo, and the type of concentration dynamics is characteristic of HGH.